Pricing Log in Create free account

Medicus Pharma Ltd (MDCX) vs Organon & Co. (OGN)

Medicus Pharma Ltd and Organon & Co. are both Drug Manufacturers General companies. Organon & Co. is the larger, with a market value of $3.6B against $3.5M — 1043.2× the size. Medicus Pharma Ltd has negative trailing earnings, so its P/E is not meaningful; Organon & Co. trades at 17.3×. Organon & Co. has the higher net margin (3.49% vs 0.00%) and the higher return on invested capital (6.26% vs −2,497.5%). Across the 12 metrics below, Organon & Co. leads on 10 and Medicus Pharma Ltd on 2.

Valuation

Metric MDCX OGN Drug Manufacturers General median
P/E n/m 17.29 26.51
P/S n/m 0.60 3.49
P/B n/m 3.04 5.28
Price to free cash flow n/m 6.35 21.67
EV/EBITDA n/m 7.51 14.73
EV/Sales n/m 1.76 4.15
Earnings yield (6,473.68%) 5.78% 2.41%
Free cash flow yield (1,401.47%) 15.75% 4.07%

Profitability

Metric MDCX OGN Drug Manufacturers General median
Gross margin — 53.12% 73.01%
Operating margin 0.00% 13.63% 18.34%
Net margin 0.00% 3.49% 7.31%
Free cash flow margin 0.00% 9.38% 18.56%
Return on equity (7,441.07%) 20.30% 5.80%
Return on assets (290.34%) 1.58% 2.28%
Return on invested capital (2,497.51%) 6.26% 6.26%

Growth

Metric MDCX OGN Drug Manufacturers General median
Revenue growth (TTM) — (3.21%) 6.72%
EPS growth (last fiscal year) (136.21%) (78.38%) 21.81%
Revenue growth, 5-year CAGR — (0.99%) 4.75%
Net income growth, 5-year CAGR — (38.70%) 0.00%

Health

Metric MDCX OGN Drug Manufacturers General median
Debt to equity (10.42) 7.17 0.62
Current ratio 1.57 2.02 1.39
Net debt to EBITDA 0.25 5.62 1.15

Dividend

Metric MDCX OGN Drug Manufacturers General median
Dividend yield — 0.58% 2.32%
Payout ratio — 0.11 0.59

Size

Metric MDCX OGN Drug Manufacturers General median
Market cap 3.47m 3.62b 129.04b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack